oracine has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavelová, M; Hladíková, J; Krcmár, P; Machala, M; Novotná, R; Skálová, L; Vildová, L; Vondrácek, J | 1 |
| Boušová, I; Hanušová, V; Pakostová, A; Skálová, L | 1 |
2 other study(ies) available for oracine and Breast Cancer
| Article | Year |
|---|---|
Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells.
Topics: 3-Hydroxysteroid Dehydrogenases; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductase Family 1 Member C3; Aldo-Keto Reductases; Biotransformation; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Induction; Enzyme Inhibitors; Ethanolamines; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Isoquinolines; Kinetics; Methacrylates; Oxidation-Reduction; Phenylpropionates; Quercetin; RNA, Messenger; Subcellular Fractions | 2008 |
The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A.
Topics: Alcohol Oxidoreductases; Animals; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytosol; Doxorubicin; Drug Interactions; Epithelial Cells; Ethanolamines; Female; Hepatocytes; Humans; Isoquinolines; Liver; Rats; Rats, Wistar | 2012 |